Additionally, CoQ10 may promote fatty acid oxidation through adenosine 5′ monophosphate-activated protein kinase (AMPK)-mediated stimulation of the peroxisome proliferator-activated receptor α (PPARα), which in turn increases the expression of LPL and apolipoprotein A1 (apo A1), potentially reducing TG and very-low-density lipoprotein levels in patients with diabetes type 2 [63]. The gene discussed is APOA1; the disease is type 2 diabetes mellitus.